Skip to content

Development and Preliminary Application of a Self-Management Support Program for Patients Undergoing Endovascular Revascularization of Arteriosclerosis Obliterans

Development and Preliminary Application of a Self-Management Support Program for Patients Undergoing Endovascular Revascularization of Arteriosclerosis Obliterans

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129607
Enrollment
Unknown
Registered
2026-08-06
Start date
2026-08-15
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis obliterans (ASO)

Interventions

Intervention group:Self-management support program after ASO intravascular revascularization
Control group:Routine health education

Sponsors

The affiliated hospital of southwest medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age 18–80 years; 2.Diagnosed with arteriosclerosis obliterans (ASO) according to the ASO diagnosis and treatment guidelines, with preoperative Rutherford classification 2–5; 3.Undergoing endovascular revascularization (including percutaneous balloon angioplasty and endovascular stenting, etc.), and assessed by two attending-level or higher physicians with >10 years of experience that residual vascular stenosis is <30% after the procedure; 4.Conscious with normal communication ability; 5.Patient and primary caregiver provide informed consent and voluntarily participate; 6.Patient owns a smartphone and is able to use the WeChat APP.

Exclusion criteria

Exclusion criteria: 1.Concomitant severe organ dysfunction (e.g., heart, brain, kidney); 2.Comorbid psychiatric or neurological disorders; 3.Comorbid malignancy; 4.Concomitant conditions that preclude exercise, such as amputation, joint disease, thrombosis, or aneurysm; 5.Currently participating in another interventional trial.

Design outcomes

Primary

MeasureTime frame
Self-Management Assessment Scale;6Min walk test distance;

Secondary

MeasureTime frame
Pain-Free Walking Distance;Rate of Achieving Exercise Targets;The 30?day Hospital Readmission Rate;Perceived social support scale;Maximal Walking Distance;Exercise Adherence Rating Scale;Adverse Events;ABI;VascuQol-6;Medication Adherence;Motivation and Attitudes Towards Changing Health;

Countries

China

Contacts

Public ContactLiu Feng

The affiliated hospital of southwest medical university

1427446608@qq.com+86 830 3165483

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026